Publication
Dose Response Relationship of Medical Cannabis and Symptom Control in Patients With Pancreatic Cancer: An Analysis of the CANPAN Trial.
Arjun Gupta, Kendall Lin, Ella Chrenka, Grace Gilmore, Jordan Cowger, David Rak, Dylan Zylla
- Source
- PubMed
- Retrieved
- Sep 26, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-PUBMED-20260926-000001
Abstract
Abstract (excerpt)
Only the opening of the abstract is shown; abstract text may carry publisher copyright.
BACKGROUND: In a pilot waitlist-control randomized trial, a personalized medical cannabis intervention improved certain symptoms among patients with pancreatic cancer over 8 weeks. Longer-term and dose-response data can guide future trial design. METHODS: CANPAN enrolled 32 cannabis-naïve patients…
Read on PubMedLinked entities
Linked entities (2)
How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.
Validated 1
- trialNCT06605430registry_reference1.00
Candidate 1
- cancerMalignant Pancreatic Neoplasmdictionary0.60
Registered trialsNCT06605430
Curated evidence
Evidence citing this paper (0)
Data not yet available